A Study to See Whether Taking a Mix of Vitamins Can Help Adults Recover Better After Surgery for Carpal Tunnel Syndrome
Effect of Oral Alpha-Lipoic Acid, Vitamin E, and Vitamin B Combination on Symptoms and Function in Carpal Tunnel Syndrome Following Carpal Tunnel Surgery
2 other identifiers
interventional
84
1 country
1
Brief Summary
Carpal Tunnel Syndrome (CTS) is a common condition that causes numbness, tingling, pain, and weakness in the hand due to compression of the median nerve at the wrist. It can affect daily activities, work performance, and quality of life. While surgery is effective in severe cases, many patients with mild to moderate CTS are initially treated with non-surgical options such as splinting and medications. However, the effectiveness of oral supplements for CTS remains uncertain. This clinical study aims to evaluate whether an oral combination of alpha-lipoic acid, Vitamin E, and Vitamin B complex can safely reduce symptoms and improve hand function in patients with Carpal Tunnel Syndrome. These supplements are believed to have antioxidant, anti-inflammatory, and nerve-protective properties, which may help reduce nerve irritation and improve nerve recovery. Participants in this study will be randomly assigned to receive either the oral supplement combination or a comparator treatment. The study is single-blinded, meaning participants will not know which treatment they are receiving. Symptoms such as pain, numbness, and hand function will be assessed over a defined follow-up period using clinical evaluation and standardized questionnaires. The main hypothesis of this study is that patients receiving the oral combination of alpha-lipoic acid, Vitamin E, and Vitamin B will experience greater improvement in symptoms and functional outcomes compared to those who do not receive the combination, without significant side effects. The results of this study may help determine whether this oral supplement combination can be used as an effective and safe conservative treatment option for patients with Carpal Tunnel Syndrome, potentially reducing the need for invasive procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 8, 2025
CompletedFirst Submitted
Initial submission to the registry
December 16, 2025
CompletedFirst Posted
Study publicly available on registry
December 31, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 8, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2027
April 23, 2026
April 1, 2026
1 year
December 16, 2025
April 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) score
The Boston Carpal Tunnel Questionnaire (BCTQ) is a patient-reported tool used to assess symptom severity and functional status in carpal tunnel syndrome. It consists of two subscales, with each item scored from 1 (no symptoms or difficulty) to 5 (most severe symptoms or inability). The final score is calculated as the mean of responses, ranging from 1 to 5. Lower scores indicate better outcomes, while higher scores indicate more severe symptoms and functional impairment.
Baseline to 12 and 24 weeks
Secondary Outcomes (1)
Change in Pain Intensity Measured by Visual Analog Scale
Baseline to 12 and 24 weeks
Study Arms (2)
Oral Antioxidant Supplement Group
EXPERIMENTALControl Group
ACTIVE COMPARATORInterventions
An oral dietary supplement containing a combination of alpha-lipoic acid, Vitamin E, and Vitamin B complex administered once daily for the study duration. The supplement is provided in capsule form and is intended to support nerve health through antioxidant and neuroprotective effects in patients with Carpal Tunnel Syndrome.
An oral Vitamin B complex supplement administered once daily for the study duration. This intervention serves as the active comparator for conservative treatment of Carpal Tunnel Syndrome.
Eligibility Criteria
You may qualify if:
- Age more than 18 years old
- Subjects with symptoms and physical examination of CTS
- Patients with CTS going for CT release
You may not qualify if:
- Pregnant or breast-feeding women
- Patients with history of trauma in the dominant hand
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital Universiti Sains Malaysialead
- BREGO Life Sciences Sdn Bhdcollaborator
Study Sites (1)
Hospital Pakar Universiti Sains Malaysia
Kubang Kerian, Kelantan, 16150, Malaysia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
nurhakim bin ibrahim
Hospital Pakar Universiti Sains Malaysia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Officer, Master Student in Orthopedic
Study Record Dates
First Submitted
December 16, 2025
First Posted
December 31, 2025
Study Start
December 8, 2025
Primary Completion (Estimated)
December 8, 2026
Study Completion (Estimated)
January 31, 2027
Last Updated
April 23, 2026
Record last verified: 2026-04